Magnetic resonance imaging of cholangiocarcinoma

Cancer Imaging

Volumn 4, Issue 2, 2004, Pages 104-115

  Vanderveen, Katrina A ^a   Hussain, Hero K ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Cholangiocarcinoma; MRCP; MRI

Indexed keywords

EID: 55049095286     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0018     Document Type: Article

References (61)

1. Buetow P, Midkiff R. Primary malignant neoplasms in the adult. MRI Clin N Am 1997; 5(2): 289-318.
2. Vilgrain V, Van Beers BE, Flejou JF et al. Intrahepatic cholangiocarcinoma: MRI and pathologiccorrelation in 14 patients. J Comput Assist Tomogr 1997; 21(1): 59-65.
3. Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 1992; 158(1): 77-9.
4. Szklaruk J, Tamm E, Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am 2002; 11(4): 865-76.
5. Craig JR, Peters RL, Edmonson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology, 2nd series, fascicle 26. Washington, DC: Armed Forces Institute of Pathology, 1989: 197-211. Radiology 1988; 16B-43.
6. Blumgart LH, Fong Y, Jarnagin W. Hepatobiliary cancer. In: American Cancer Society Atlas of Clinical Oncology Series, Hamilton, Ontario: BC Decker, 2001: 193-209.
7. Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW. Intrahepatic cholangiocarcinoma: radiologic pathologic correlation. Radiology 1988; 167: 689-93.
8. Manfredi R, Masselli G, Maresca G, Brizi MG, Vecchioli A, Marano P. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 2003; 28: 319-25.
9. Jarnagin WR. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 2000; 19: 156-76.
10. Pavone P. MR cholangiopancreatography in malignant biliary obstruction. Semin Ultrasound CT MRI 1999; 20(5): 317-23.
11. Jarnagin WR, Fong Y, DeMatteo RP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234(4): 507-19.
12. Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma. Clin Liver Dis 2001; 5(1): 191-218.
13. Choi B. MRI of clonorchiasis and cholangiocarcinoma. J Magn Reson Imaging 1998; 8(2): 359-66.
14. Khan SA, Davidson BR, Goldin R et al. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 (Suppl 6): VI1-9.
15. Levy AD. Malignant liver tumors. Clin Liver Dis 2002; 6(1): 147-64.
16. Goss JA, Shackleton CR, McDiarmid SV et al. Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg 1998; 228(3): 411-20.
17. Ahrendt SA, Pitt HA, Nakeeb A et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg 1999; 3(4): 357-67.
18. Nakeeb A, Pitt HA, Sohn TA et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224(4): 463-73.
19. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341(18): 1368-78.
20. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-56.
21. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 12(4): 288-91.
22. Lee WJ, Lim HK, Jang KM et al. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 2001; 21: S97-S116.
23. Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003; 10(4): 265-81.
24. Rubin E, Farber J. Pathology, 2nd edn. Philadelphia, PA: J.B. Lippincott, 1994: 773-4.
25. Maetani Y, Itoh K, Watanabe C et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176(6): 1499-507.
26. Kehagias D, Metafa A, Hatziioannou A et al. Comparison of CT, MRI and CT during arterial portography in the detection of malignant hepatic lesions. Hepatogastroenterology 2000; 47(35): 1399-403.
27. Soyer P, Bluemke DA, Reichle R et al. Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma. AJR Am J Roentgenol 1995; 165(6): 1433-6.
28. Hultcrantz R, Olsson R, Danielsson A et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999; 30(4): 669-73.
29. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108(3): 865-9.
30. Baer H, Stain S, Dennison A et al. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1992; 217: 20-7.
31. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215(1): 31-8.
32. Langer JC, Langer B, Taylor BR et al. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery 1985; 98: 752-9.
33. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140(2): 170-8.
34. Lee SS, Kim MH, Lee SK et al. MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. Gastrointest Endosc 2002; 56(1): 25-32.
35. Soyer P, Bluemke DA, Reichle R et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol 1995; 165: 1427-31.
36. Zhang Y. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 1999; 23(5): 670-7.
37. Murakami T, Nakamura H, Tsuda K et al. Contrastenhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study. J Magn Reson Imaging 1995; 5(2): 165-70.
38. Low RN. MR imaging of the liver using gadolinium chelates. Magn Reson Imaging Clin N Am 2001; 9(4): 717-43.
39. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 1998; 16(9): 993-1003.
40. Greco A, Stipa F, Huguet C, Gavelli A, Chieco PA, McNamara MT. Early MR follow-up of partial hepatectomy. J Comput Assist Tomogr 1993; 17(2): 277-82.
41. Soyer P, Bluemke DA, Sibert A, Laissy JP. MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging 1995; 20(2): 126-30.
42. Dooms GC, Kerlan RK Jr, Hricak H, Wall SD, Margulis AR. Cholangiocarcinoma: imaging by MR. Radiology 1986; 159: 89-94.
43. Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 1996; 201(2): 347-51.
44. Awaya H. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 1998; 22: 180-7.
45. Gabata T, Matsui O, Kadoya M et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998; 23(3): 309-13.
46. Peterson MS, Murakami T, Baron RL. MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging 1998; 23(6): 592-9.
47. Fan ZM, Yamashita Y, Harada M et al. Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 1993; 161(2): 313-7.
48. Yamashita Y. Parenchymal changes of the liver in cholangiocarcinoma: CT evaluation. Gastrointest Radiol 1992; 17: 161-6.
49. Semelka R. Abdominal-Pelvic MRI, New York: Wiley-Liss, 2002: 358-65.
50. Yoshimitsu K, Honda H, Kaneko K et al. MR signal intensity changes in hepatic parenchyma with ductal dilation caused by intrahepatic cholangiocarcinoma. J Magn Reson Imaging 1997; 7(1): 136-41.
51. Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradientrecalled and spin-echo imaging. AJR Am J Roentgenol 1994; 163(5): 1131-40.
52. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997; 204(2): 513-20.
53. Itai Y, Ohtomo K, Kokubo T et al. CT of hepatic masses: significance of prolonged and delayed enhancement. AJR Am J Roentgenol 1986; 146: 729-33.
54. Fernandez M, Redyanly RD. Primary hepatic malignant neoplasms. Radiol Clin N Am 1998; 36(2): 333-48.
55. Lee MG, Park KB, Shin YM et al. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg 2003; 27(3): 278-83.
56. Hann LE, Schwartz LH, Panicek DM, Bach AM, Fong Y, Blumgart LH. Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 1998; 206(3): 651-6.
57. Yeh TS, Jan YY, Tseng JH et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 2000; 95(2): 432-40.
58. Reinhold C, Bret PM. Current status of MR cholangiopancreatography. AJR Am J Roentgenol 1996; 166: 1285-95.
59. Fulcher AS, Turner MA. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. AJR Am J Roentgenol 1997; 169(6): 1501-5.
60. Thng C, Tan A, Chung Y, Chow P, Ooi L. Clinical applications of MR cholangiopancreatography. Ann Acad Med Singapore 2003; 32(4): 536-41.
61. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. New York: International Union Against Cancer/Wiley-Liss, 2002: p. 87.